US Stock MarketDetailed Quotes

ABUS Arbutus Biopharma

Watchlist

3.200
-0.140-4.19%

Close Jun 7 16:00 ET

3.130
-0.070-2.19%

Post 19:21 ET

603.90MMarket Cap-7272P/E (TTM)

Arbutus Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

29.32%-19.3M

-143.06%-85.94M

-1.78%-17.29M

-16.54%-21.78M

3.62%-19.56M

-232.41%-27.3M

47.65%-35.36M

13.34%-16.99M

-16.56%-18.69M

-44.86%-20.29M

Net income from continuing operations

-9.40%-17.88M

-4.89%-72.85M

11.95%-19.31M

-14.44%-20.1M

-20.45%-17.09M

-3.64%-16.34M

8.91%-69.46M

-2.87%-21.93M

8.30%-17.57M

26.80%-14.19M

Operating gains losses

----

---20K

--0

----

--0

----

Depreciation and amortization

6.29%355K

-1.61%1.4M

16.94%359K

7.58%369K

-10.70%342K

-15.23%334K

-18.60%1.43M

-28.10%307K

-23.27%343K

-12.16%383K

Other non cash items

46.75%-377K

9.60%-3.34M

-171.93%-930K

72.27%-472K

-23.55%-1.23M

-7.93%-708K

-166.81%-3.7M

75.47%-342K

-600.41%-1.7M

-421.94%-998K

Change In working capital

76.82%-2.86M

-162.35%-18.23M

-57.68%1.49M

-141.57%-3.38M

47.41%-4M

-135.50%-12.33M

3,061.41%29.24M

249.65%3.51M

-233.72%-1.4M

-393.37%-7.61M

-Change in receivables

72.33%-363K

6.40%-424K

-18.22%395K

228.15%443K

107.61%50K

-216.91%-1.31M

-209.69%-453K

-37.11%483K

136.59%135K

-1,890.91%-657K

-Change in prepaid assets

66.67%-156K

-138.81%-943K

-54.35%1.1M

-226.89%-1.46M

-128.61%-109K

68.94%-468K

337.07%2.43M

350.84%2.4M

208.29%1.15M

-8.41%381K

-Change in payables and accrued expense

68.26%-2.02M

-210.39%-5.76M

-87.63%465K

590.69%1M

-122.54%-848K

-203.33%-6.38M

172.95%5.22M

183.56%3.76M

-117.48%-204K

69.92%3.76M

-Change in other current liabilities

2.70%-72K

-9.63%-444K

-25.00%-155K

-7.58%-142K

1.35%-73K

1.33%-74K

-8.29%-405K

5.34%-124K

-5.60%-132K

-3,600.00%-74K

-Change in other working capital

94.05%-244K

-147.49%-10.66M

89.53%-315K

-36.95%-3.22M

72.57%-3.02M

-110.57%-4.1M

--22.46M

---3.01M

---2.35M

---11.03M

Cash from discontinued investing activities

Operating cash flow

29.32%-19.3M

-143.06%-85.94M

-1.78%-17.29M

-16.54%-21.78M

3.62%-19.56M

-232.41%-27.3M

47.65%-35.36M

13.34%-16.99M

-16.56%-18.69M

-44.86%-20.29M

Investing cash flow

Cash flow from continuing investing activities

-29.88%11.69M

167.75%50.77M

75.25%22.23M

175.91%10.43M

110.42%1.44M

127.77%16.68M

-491.12%-74.94M

256.16%12.68M

-186.03%-13.74M

64.31%-13.83M

Net PPE purchase and sale

18.80%-95K

-92.97%-988K

--0

86.81%-12K

-347.40%-859K

-56.00%-117K

36.71%-512K

-165.52%-154K

-355.00%-91K

69.62%-192K

Net business purchase and sale

0.50%37.19M

----

--37M

----

Net investment purchase and sale

-25.70%-25.4M

169.54%51.76M

73.15%22.23M

176.51%10.44M

388.17%39.3M

66.31%-20.21M

-527.10%-74.43M

259.20%12.84M

-185.35%-13.65M

64.22%-13.64M

Cash from discontinued investing activities

Investing cash flow

-29.88%11.69M

167.75%50.77M

75.25%22.23M

175.91%10.43M

110.42%1.44M

127.77%16.68M

-491.12%-74.94M

256.16%12.68M

-186.03%-13.74M

64.31%-13.83M

Financing cash flow

Cash flow from continuing financing activities

19.66%24.43M

-3.67%30.65M

-65.65%3.81M

-81.59%1.68M

4,096.46%4.74M

77.77%20.42M

-76.82%31.81M

-81.25%11.08M

-80.55%9.13M

-97.37%113K

Net common stock issuance

9.58%21.77M

46.88%29.85M

-65.24%3.85M

-84.44%1.4M

--4.74M

7,311.19%19.86M

-84.91%20.32M

-81.29%11.08M

-79.94%8.97M

--0

Proceeds from stock option exercised by employees

380.18%2.67M

-93.08%795K

-4,600.00%-45K

79.25%285K

--0

-95.05%555K

346.91%11.49M

100.87%1K

-92.82%159K

653.33%113K

Cash from discontinued financing activities

Financing cash flow

19.66%24.43M

-3.67%30.65M

-65.65%3.81M

-81.59%1.68M

4,096.46%4.74M

77.77%20.42M

-76.82%31.81M

-81.25%11.08M

-80.55%9.13M

-97.37%113K

Net cash flow

Beginning cash position

-14.59%26.29M

-71.84%30.78M

-26.97%17.53M

-42.53%27.2M

-50.11%40.57M

-71.84%30.78M

109.15%109.28M

-69.18%24M

52.87%47.32M

2.40%81.33M

Current changes in cash

71.83%16.83M

94.25%-4.52M

28.98%8.74M

58.48%-9.67M

60.67%-13.38M

135.04%9.79M

-237.63%-78.48M

-78.42%6.78M

-149.69%-23.3M

29.83%-34.01M

Effect of exchange rate changes

-425.00%-13K

213.64%25K

450.00%14K

144.44%8K

---1K

--4K

-540.00%-22K

-180.00%-4K

-140.91%-18K

--0

End cash Position

6.23%43.1M

-14.59%26.29M

-26.97%17.53M

-42.53%27.2M

-50.11%40.57M

-71.84%30.78M

-69.18%24M

52.87%47.32M

Free cash flow

29.28%-19.39M

-142.40%-86.94M

-0.98%-17.29M

-16.15%-21.82M

0.42%-20.42M

-233.46%-27.42M

47.52%-35.87M

12.92%-17.12M

-16.98%-18.78M

-40.05%-20.51M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	29.32%-19.3M	-143.06%-85.94M	-1.78%-17.29M	-16.54%-21.78M	3.62%-19.56M	-232.41%-27.3M	47.65%-35.36M	13.34%-16.99M	-16.56%-18.69M	-44.86%-20.29M
Net income from continuing operations	-9.40%-17.88M	-4.89%-72.85M	11.95%-19.31M	-14.44%-20.1M	-20.45%-17.09M	-3.64%-16.34M	8.91%-69.46M	-2.87%-21.93M	8.30%-17.57M	26.80%-14.19M
Operating gains losses	----	---20K	--0	----	----	----	----	----	--0	----
Depreciation and amortization	6.29%355K	-1.61%1.4M	16.94%359K	7.58%369K	-10.70%342K	-15.23%334K	-18.60%1.43M	-28.10%307K	-23.27%343K	-12.16%383K
Other non cash items	46.75%-377K	9.60%-3.34M	-171.93%-930K	72.27%-472K	-23.55%-1.23M	-7.93%-708K	-166.81%-3.7M	75.47%-342K	-600.41%-1.7M	-421.94%-998K
Change In working capital	76.82%-2.86M	-162.35%-18.23M	-57.68%1.49M	-141.57%-3.38M	47.41%-4M	-135.50%-12.33M	3,061.41%29.24M	249.65%3.51M	-233.72%-1.4M	-393.37%-7.61M
-Change in receivables	72.33%-363K	6.40%-424K	-18.22%395K	228.15%443K	107.61%50K	-216.91%-1.31M	-209.69%-453K	-37.11%483K	136.59%135K	-1,890.91%-657K
-Change in prepaid assets	66.67%-156K	-138.81%-943K	-54.35%1.1M	-226.89%-1.46M	-128.61%-109K	68.94%-468K	337.07%2.43M	350.84%2.4M	208.29%1.15M	-8.41%381K
-Change in payables and accrued expense	68.26%-2.02M	-210.39%-5.76M	-87.63%465K	590.69%1M	-122.54%-848K	-203.33%-6.38M	172.95%5.22M	183.56%3.76M	-117.48%-204K	69.92%3.76M
-Change in other current liabilities	2.70%-72K	-9.63%-444K	-25.00%-155K	-7.58%-142K	1.35%-73K	1.33%-74K	-8.29%-405K	5.34%-124K	-5.60%-132K	-3,600.00%-74K
-Change in other working capital	94.05%-244K	-147.49%-10.66M	89.53%-315K	-36.95%-3.22M	72.57%-3.02M	-110.57%-4.1M	--22.46M	---3.01M	---2.35M	---11.03M
Cash from discontinued investing activities
Operating cash flow	29.32%-19.3M	-143.06%-85.94M	-1.78%-17.29M	-16.54%-21.78M	3.62%-19.56M	-232.41%-27.3M	47.65%-35.36M	13.34%-16.99M	-16.56%-18.69M	-44.86%-20.29M
Investing cash flow
Cash flow from continuing investing activities	-29.88%11.69M	167.75%50.77M	75.25%22.23M	175.91%10.43M	110.42%1.44M	127.77%16.68M	-491.12%-74.94M	256.16%12.68M	-186.03%-13.74M	64.31%-13.83M
Net PPE purchase and sale	18.80%-95K	-92.97%-988K	--0	86.81%-12K	-347.40%-859K	-56.00%-117K	36.71%-512K	-165.52%-154K	-355.00%-91K	69.62%-192K
Net business purchase and sale	0.50%37.19M	----	----	----	----	--37M	----	----	----	----
Net investment purchase and sale	-25.70%-25.4M	169.54%51.76M	73.15%22.23M	176.51%10.44M	388.17%39.3M	66.31%-20.21M	-527.10%-74.43M	259.20%12.84M	-185.35%-13.65M	64.22%-13.64M
Cash from discontinued investing activities
Investing cash flow	-29.88%11.69M	167.75%50.77M	75.25%22.23M	175.91%10.43M	110.42%1.44M	127.77%16.68M	-491.12%-74.94M	256.16%12.68M	-186.03%-13.74M	64.31%-13.83M
Financing cash flow
Cash flow from continuing financing activities	19.66%24.43M	-3.67%30.65M	-65.65%3.81M	-81.59%1.68M	4,096.46%4.74M	77.77%20.42M	-76.82%31.81M	-81.25%11.08M	-80.55%9.13M	-97.37%113K
Net common stock issuance	9.58%21.77M	46.88%29.85M	-65.24%3.85M	-84.44%1.4M	--4.74M	7,311.19%19.86M	-84.91%20.32M	-81.29%11.08M	-79.94%8.97M	--0
Proceeds from stock option exercised by employees	380.18%2.67M	-93.08%795K	-4,600.00%-45K	79.25%285K	--0	-95.05%555K	346.91%11.49M	100.87%1K	-92.82%159K	653.33%113K
Cash from discontinued financing activities
Financing cash flow	19.66%24.43M	-3.67%30.65M	-65.65%3.81M	-81.59%1.68M	4,096.46%4.74M	77.77%20.42M	-76.82%31.81M	-81.25%11.08M	-80.55%9.13M	-97.37%113K
Net cash flow
Beginning cash position	-14.59%26.29M	-71.84%30.78M	-26.97%17.53M	-42.53%27.2M	-50.11%40.57M	-71.84%30.78M	109.15%109.28M	-69.18%24M	52.87%47.32M	2.40%81.33M
Current changes in cash	71.83%16.83M	94.25%-4.52M	28.98%8.74M	58.48%-9.67M	60.67%-13.38M	135.04%9.79M	-237.63%-78.48M	-78.42%6.78M	-149.69%-23.3M	29.83%-34.01M
Effect of exchange rate changes	-425.00%-13K	213.64%25K	450.00%14K	144.44%8K	---1K	--4K	-540.00%-22K	-180.00%-4K	-140.91%-18K	--0
End cash Position	6.23%43.1M	-14.59%26.29M	-14.59%26.29M	-26.97%17.53M	-42.53%27.2M	-50.11%40.57M	-71.84%30.78M	-71.84%30.78M	-69.18%24M	52.87%47.32M
Free cash flow	29.28%-19.39M	-142.40%-86.94M	-0.98%-17.29M	-16.15%-21.82M	0.42%-20.42M	-233.46%-27.42M	47.52%-35.87M	12.92%-17.12M	-16.98%-18.78M	-40.05%-20.51M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall